Bunzl bundles up
in Meds & PPE
Reports double digit sales
growth from price inflation
Bunzl, the $14Bn international business supplies wholesaler reported preliminary results for 2022. Real organic volume growth was marginal and continued to be boosted by high inflationary prices. CEO Frank van Zanten commented 4 acquisitions in Q4 (approx $50m in sales) and a healthcare unit disposal
